267 related articles for article (PubMed ID: 33827960)
1. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Rojas JC; Wang P; Staffaroni AM; Heller C; Cobigo Y; Wolf A; Goh SM; Ljubenkov PA; Heuer HW; Fong JC; Taylor JB; Veras E; Song L; Jeromin A; Hanlon D; Yu L; Khinikar A; Sivasankaran R; Kieloch A; Valentin MA; Karydas AM; Mitic LL; Pearlman R; Kornak J; Kramer JH; Miller BL; Kantarci K; Knopman DS; Graff-Radford N; Petrucelli L; Rademakers R; Irwin DJ; Grossman M; Ramos EM; Coppola G; Mendez MF; Bordelon Y; Dickerson BC; Ghoshal N; Huey ED; Mackenzie IR; Appleby BS; Domoto-Reilly K; Hsiung GR; Toga AW; Weintraub S; Kaufer DI; Kerwin D; Litvan I; Onyike CU; Pantelyat A; Roberson ED; Tartaglia MC; Foroud T; Chen W; Czerkowicz J; Graham DL; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Rowe JB; Masellis M; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Cash DM; Convery RS; Bocchetta M; Foiani M; Greaves CV; Peakman G; Russell L; Swift I; Todd E; Rohrer JD; Boeve BF; Rosen HJ; Boxer AL;
Neurology; 2021 May; 96(18):e2296-e2312. PubMed ID: 33827960
[TBL] [Abstract][Full Text] [Related]
2. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
[TBL] [Abstract][Full Text] [Related]
4. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers.
Casaletto KB; Kornack J; Paolillo EW; Rojas JC; VandeBunte A; Staffaroni AS; Lee S; Heuer H; Forsberg L; Ramos EM; Miller BL; Kramer JH; Yaffe K; Petrucelli L; Boxer A; Boeve B; Gendron TF; Rosen H;
JAMA Neurol; 2023 Jan; 80(1):82-90. PubMed ID: 36374516
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Peakman G; Russell LL; Convery RS; Nicholas JM; Van Swieten JC; Jiskoot LC; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tagliavini F; Santana I; Pasquier F; Levin J; Danek A; Otto M; Sorbi S; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):158-168. PubMed ID: 34353857
[TBL] [Abstract][Full Text] [Related]
6. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of serum NfL and p-Tau
Benussi A; Karikari TK; Ashton N; Gazzina S; Premi E; Benussi L; Ghidoni R; Rodriguez JL; Emeršič A; Simrén J; Binetti G; Fostinelli S; Giunta M; Gasparotti R; Zetterberg H; Blennow K; Borroni B
J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):960-967. PubMed ID: 32611664
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.
Poos JM; MacDougall A; van den Berg E; Jiskoot LC; Papma JM; van der Ende EL; Seelaar H; Russell LL; Peakman G; Convery R; Pijnenburg YAL; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; Mendonça A; Tiraboschi P; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Le Ber I; Pasquier F; van Swieten J; Rohrer JD;
Neurology; 2022 Jul; 99(3):e281-e295. PubMed ID: 35483895
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
Cajanus A; Katisko K; Kontkanen A; Jääskeläinen O; Hartikainen P; Haapasalo A; Herukka SK; Vanninen R; Solje E; Hall A; Remes AM
Ann Clin Transl Neurol; 2020 Jun; 7(6):903-910. PubMed ID: 32441885
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
[TBL] [Abstract][Full Text] [Related]
11. Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration.
Asken BM; Ljubenkov PA; Staffaroni AM; Casaletto KB; Vandevrede L; Cobigo Y; Rojas-Rodriguez JC; Rankin KP; Kornak J; Heuer H; Shigenaga J; Appleby BS; Bozoki AC; Domoto-Reilly K; Ghoshal N; Huey E; Litvan I; Masdeu JC; Mendez MF; Pascual B; Pressman P; Tartaglia MC; Kremers W; Forsberg LK; Boeve BF; Boxer AL; Rosen HJ; Kramer JH;
J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):541-549. PubMed ID: 36977552
[TBL] [Abstract][Full Text] [Related]
12. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
15. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
Staffaroni AM; Bajorek L; Casaletto KB; Cobigo Y; Goh SM; Wolf A; Heuer HW; Elahi FM; Ljubenkov PA; Dever R; Kornak J; Appleby B; Bove J; Bordelon Y; Brannelly P; Brushaber D; Caso C; Coppola G; Dheel C; Dickerson BC; Dickinson S; Dominguez S; Domoto-Reilly K; Faber K; Ferrall J; Fields JA; Fishman A; Fong J; Foroud T; Forsberg LK; Gavrilova R; Gearhart D; Ghazanfari B; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford N; Grant I; Grossman M; Haley D; Hsiung GY; Huey ED; Irwin DJ; Jones DT; Jones L; Kantarci K; Karydas A; Kaufer DI; Kerwin DR; Knopman DS; Kraft R; Kremers WK; Kukull WA; Litvan I; Lucente D; Lungu C; Mackenzie IR; Maldonado M; Manoochehri M; McGinnis SM; McKinley E; Mendez MF; Miller BL; Multani N; Onyike C; Padmanabhan J; Pantelyat A; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Roberson ED; Rogalski E; Sengdy P; Shaw LM; Syrjanen J; Tartaglia MC; Tatton N; Taylor J; Toga A; Trojanowski JQ; Weintraub S; Wang P; Wong B; Wszolek Z; Boxer AL; Boeve BF; Kramer JH; Rosen HJ;
Alzheimers Dement; 2020 Jan; 16(1):11-21. PubMed ID: 31914230
[TBL] [Abstract][Full Text] [Related]
16. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
17. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia.
Samra K; Peakman G; MacDougall AM; Bouzigues A; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Ber IL; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
Alzheimers Dement (Amst); 2024; 16(2):e12571. PubMed ID: 38623386
[TBL] [Abstract][Full Text] [Related]
18. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.
Chen Q; Boeve BF; Senjem M; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Graff-Radford J; Graff-Radford N; Jack CR; Jones D; Knopman D; Kremers WK; Lapid M; Rademakers R; Ramos EM; Syrjanen J; Boxer AL; Rosen H; Wszolek ZK; Kantarci K
Neurobiol Aging; 2020 Apr; 88():42-50. PubMed ID: 31918955
[TBL] [Abstract][Full Text] [Related]
19. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
[TBL] [Abstract][Full Text] [Related]
20. Plasma NfL levels and longitudinal change rates in
Saracino D; Dorgham K; Camuzat A; Rinaldi D; Rametti-Lacroux A; Houot M; Clot F; Martin-Hardy P; Jornea L; Azuar C; Migliaccio R; Pasquier F; Couratier P; Auriacombe S; Sauvée M; Boutoleau-Bretonnière C; Pariente J; Didic M; Hannequin D; Wallon D; ; ; Colliot O; Dubois B; Brice A; Levy R; Forlani S; Le Ber I
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1278-1288. PubMed ID: 34349004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
